CLINICAL_TRIALS
trial_result
· 2016-09-08
Clinical Trial Update: Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration [Phase 2]
Summary
A Phase 2 trial evaluating regorafenib eye drops for neovascular age-related macular degeneration was terminated, with results posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bayer | Conditions: Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2016-09-08